Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
Craig Meagher(Western University), Terry L. Delovitch(Western University), William W. Cruikshank(Boston University)
Cited by 0
Related Papers
Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway
|The Journal of Immunology|2003|294
Interleukin-16
|Journal of Leukocyte Biology|2000|277
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.
|Proceedings of the National Academy of Sciences|1994|270
Interleukin 16 and its function as a CD4 ligand
|Immunology Today|1996|255
Identification of HIV-1 Envelope Glycoprotein in the Serum of AIDS and ARC Patients
|JAIDS Journal of Acquired Immune Deficiency Syndromes|1992|233